Galantamine/Metformin

加兰他敏/二甲双胍

Report date: 2025/07/30 14:53:55

Base Information

Drug NameGalantamine/Metformin
Drug Alias NameRJx-01
ClassificationSmall molecules
Mechanisms of ActionAcetylcholinesterase inhibitorsProtein kinase AMP-activated non-catalytic subunit beta 1 activators
TargetsAcetylcholinesteraseProtein kinase AMP-activated non-catalytic subunit beta 1
Therapy Area/IndicationsSarcopeniaMuscular AtrophyMuscle Weakness
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes Galantamine HydrobromideMetformin Hydrochloride
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesRejuvenate Biomed NV
China Registration ClassN/A

Develop Information

Active CompaniesRejuvenate Biomed NV
Inactive CompaniesN/A
Active IndicationsSarcopeniaMuscular AtrophyMuscle Weakness
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A